# Jinggong Hongyuan

> Jinggong Hongyuan is a VC fund in Beijing backing Therapeutics and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 1
- Last investment: Nov 2017
- Lead investor: 0%
- Last updated: Aug 2026

Jinggong Hongyuan is a science & technology achievement transformation and industrialization fund focuses on the emerging industries.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |
| Clinical Trials | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cygnus Biosciences | Cygnus Biosciences (Beijing) Co., Ltd. is a high-tech company specializing in R & D and industrialization of gene sequencing platform and committed to clinical medicine screening and diagnosis. | $19.6M | Series B | Nov 14, 2017 |  |

1 of 1 investments shown.

## Co-investors
- [General Technology Venture Capital](https://shizune.co/investors/profile/general-technology-venture-capital) — VC Fund, 1 deal together
- [Lapam Capital](https://shizune.co/investors/profile/lapam-capital) — VC Fund, 1 deal together
- [Proxima Ventures Ltd](https://shizune.co/investors/profile/proxima) — VC Fund, 1 deal together
- [Prox Ventures](https://shizune.co/investors/profile/prox-ventures) — VC Fund, 1 deal together
- [Shanghai Creation Investment](https://shizune.co/investors/profile/shanghai-creation-investment-management-co-ltd) — VC Fund, 1 deal together
- [ZGC Group](https://shizune.co/investors/profile/zgc-group) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Jinggong Hongyuan invest in?

Jinggong Hongyuan invests primarily in Therapeutics, Biotechnology and Pharmaceutical startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jinggong Hongyuan last invest?

The most recent investment recorded for Jinggong Hongyuan closed in Nov 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co